Skip to main content
. 2014 Mar 14;10(6):1645–1649. doi: 10.4161/hv.28420

Table 1. Safety comparison between the Zagreb and Essen regimens used in patients with WHO category II exposure to rabies.

  Zagreb Essen P
  0–5 y old# 6–18 y old 19–59 y old 60+ years old Total 0–5 y old# 6–18 y old 19–59 y old 60+ years old Total  
Sex, M/F 11/14 15/17 18/20 15/22 59/73 12/16 17/12 18/19 14/18 61/65 0.907
Mean age (SD) 41.92 (11.66) m 15.22 (3.12) y 46.26 (11.12) y 73.49 (7.37) y 38.13 (27.08) y 37.18 (12.53) m 14.48 (2.84) y 43.68 (11.76) y 69.56 (5.81) y 35.83 (26.48) y 0.459
Systemic symptoms (occurring during first immunization)* 16(15) 5(5) 2(2) 4(4) 27(26) 12(10) 3(3) 2(2) 3(3) 20(18) 0.341
Fever 12 1 1 1 15 8 2 1 1 12  
Malaise 0 2 1 2 5 0 0 0 2 2  
Allergy 1 1 0 0 2 2 0 1 0 3  
Restlessness 0 1 0 0 1 1 1 0 0 1  
Nausea and vomiting 2 0 0 0 2 1 0 0 0 1  
Diarrhea 1 0 0 1 2 0 0 0 0 0  
Local symptoms (occurring during first immunization)* 5(5) 14(12) 5(4) 16(13) 40(34) 5(5) 13(9) 4(3) 12(10) 34 (27) 0.556
Pain 1 9 3 11 24 0 10 2 6 18  
Induration 2 2 1 0 5 2 1 0 2 5  
Edema 1 1 0 1 3 1 1 1 1 4  
Tenderness 1 2 1 3 7 1 1 1 3 6  
Erythema 0 0 0 1 1 1 0 0 0 1  

*Data in brackets show the number of side effects after first immunization, which have no significant differences of total side effects incidence between Zagreb and Essen in systemic symptoms (P = 0.383, 26/27 vs 18/20) or local symptoms (P = 0.529, 34/40 vs 27/34). #Although the difference in side effects of <5-y-old patients between Zagreb and Essen (P = 0.060, 21/25 vs 17/28) was not statistically significant, it was found to be statistically significant after the first-dose immunization (P =0.043, 20/25 vs 15/28). m, months; y, years.